Northland Securities Predicts Astera Labs Q2 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Stock analysts at Northland Securities issued their Q2 2027 earnings estimates for shares of Astera Labs in a research report issued on Wednesday, February 11th. Northland Securities analyst G. Richard anticipates that the company will earn $0.51 per share for the quarter. Northland Securities currently has a “Outperform” rating and a $195.00 target price on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $0.34 per share. Northland Securities also issued estimates for Astera Labs’ Q3 2027 earnings at $0.55 EPS and Q4 2027 earnings at $0.67 EPS.

A number of other equities analysts have also recently commented on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Raymond James Financial initiated coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating on the stock. Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Finally, Needham & Company LLC raised their target price on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $129.32 on Friday. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The company’s fifty day simple moving average is $164.09 and its 200-day simple moving average is $174.12. The stock has a market capitalization of $21.84 billion, a PE ratio of 106.00, a P/E/G ratio of 2.74 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period in the previous year, the business posted $0.37 earnings per share. The firm’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS.

Institutional Trading of Astera Labs

Several hedge funds have recently bought and sold shares of the stock. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Astera Labs by 21.6% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of Astera Labs by 94.6% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after acquiring an additional 53,276 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its position in Astera Labs by 142.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 11,366 shares of the company’s stock worth $1,028,000 after acquiring an additional 6,677 shares in the last quarter. Harbour Investments Inc. grew its position in Astera Labs by 207.7% in the second quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock worth $221,000 after acquiring an additional 1,651 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Astera Labs by 34.5% during the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after acquiring an additional 133,961 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares of the company’s stock, valued at $21,275,217.60. This trade represents a 3.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director directly owned 1,574,498 shares in the company, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 576,936 shares of company stock worth $87,409,540 over the last ninety days. 12.50% of the stock is owned by company insiders.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.